Transcatheter Aortic Valve Replacement Market 2024 – Size, Industry Share, Trends And Forecast To 2033 | Abbott Laboratories Inc., Medtronic PLC, Boston Scientific Corporation, Hilton Worldwide Holdings Inc., Edwards Lifesciences Co

The Transcatheter Aortic Valve Replacement Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Transcatheter Aortic Valve Replacement Market:
https://www.thebusinessresearchcompany.com/report/transcatheter-aortic-valve-replacement-global-market-report

According to The Business Research Company’s Transcatheter Aortic Valve Replacement Global Market Report 2024, The transcatheter aortic valve replacement market size has grown rapidly in recent years. It will grow from $4.63 billion in 2023 to $5.32 billion in 2024 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to rising prevalence of aortic regurgitation, rising prevalence of cardiovascular diseases, increasing patient preference for minimally invasive therapies, global expansion of tavr procedures, favorable reimbursement policies..

The transcatheter aortic valve replacement market size is expected to see rapid growth in the next few years. It will grow to $8.79 billion in 2028 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to increasing prevalence of aortic stenosis, growing adoption of minimally invasive procedures, expansion of indications for tavr procedures, favorable reimbursement policies, rising awareness of tavr as a viable treatment avenue.. Major trends in the forecast period include continuous evolution of device technology, rising prevalence of cardiovascular diseases, global expansion of tavr procedures, aging demographic, rising healthcare expenditure..

The increase in the prevalence of aortic stenosis is one of the driving factors for the transcatheter aortic valve replacement market going forward. Aortic stenosis is a medical condition that refers to the narrowing the aortic valve in the heart. It can be treated with transcatheter aortic valve replacement (TAVR), a less invasive alternative to surgical aortic valve replacement (SAVR) that aid in restoring blood flow and reducing the signs and symptoms of aortic valve stenosis. For instance, in August 2021, according to the report published by the Baker Heart and Diabetes Institute, an Australia-based research institute, 500,000 and 600,000 Australians in 2021 were suffering from heart valve disease. Further, Aortic stenosis cases are expected to rise to 200,000 in 2031 and 266,000 in 2051, respectively. Therefore, the increase in the prevalence of aortic stenosis is driving the transcatheter aortic valve replacement market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=12031&type=smp

The transcatheter aortic valve replacement market covered in this report is segmented –
1) Transcatheter Aortic Valve Replacement Market By Product: Self-Expandable Transcatheter Aortic Valves, Balloon-Expandable Transcatheter Aortic Valves, Mechanically Expanded Transcatheter Aortic Valves
2) Transcatheter Aortic Valve Replacement Market By Material: Valve Frame Material, Valve Leaflet Material
3) Transcatheter Aortic Valve Replacement Market By Procedure: Transfemoral Implantation, Transapical Implantation, Transaortic Implantation
4) Transcatheter Aortic Valve Replacement Market By Application: Aortic Stenosis, Aortic Regurgitation, Other Applications
5) Transcatheter Aortic Valve Replacement Market By End-User: Hospitals, Independent Cardiac Catheterization Labs, Ambulatory Surgical Centers, Other End-Users

Top Major Players

Abbott Laboratories Inc.

Medtronic PLC

Boston Scientific Corporation

Hilton Worldwide Holdings Inc.

Edwards Lifesciences Co

Product innovation is a key trend gaining traction in the transcatheter aortic valve replacement (TAVR) market. Companies operating in the transcatheter aortic valve replacement sector are focused on developing new technological and innovative solutions to strengthen their position in the market. For instance, in August 2021, Medtronic, a US-based medical device company, got approval for its Evolut FX TAVR system from U.S. Food and Drug Administration (FDA), a US-based federal agency. Evolut FX TAVR system is the newest-generation, self-expanding transcatheter aortic valve replacement system designed to enhance ease of use and provide greater precision and control throughout the procedure. The Evolut FX system uses the same supra-annular valve design that has been found to outperform surgical aortic valve replacement (SAVR) in large-scale, randomized clinical trials. The Evolut FX system includes a modified catheter tip for a smoother insertion profile and a more flexible delivery system with 360-degree freedom of motion and reliable, predictable deployment. Like its predecessor (Evolut PRO+), the new system has four-valve sizes for the greatest indicated patient treatment range and the lowest delivery profile currently available.

The transcatheter aortic valve replacement market report table of contents includes:

1. Executive Summary

2. Transcatheter Aortic Valve Replacement Market Characteristics

3. Transcatheter Aortic Valve Replacement Market Trends And Strategies

4. Transcatheter Aortic Valve Replacement Market – Macro Economic Scenario

5. Global Transcatheter Aortic Valve Replacement Market Size and Growth

…….

32. Global Transcatheter Aortic Valve Replacement Market Competitive Benchmarking

33. Global Transcatheter Aortic Valve Replacement Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Transcatheter Aortic Valve Replacement Market

35. Transcatheter Aortic Valve Replacement Market Future Outlook and Potential Analysis

36. Appendix